PROCYSBI (Horizon Pharma Inc.)


Welcome to the PulseAid listing for the PROCYSBI drug offered from Horizon Pharma Inc.. This Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Horizon Pharma Inc.
NON-PROPRIETARY NAME: Cysteamine bitartrate
SUBSTANCE NAME: CYSTEAMINE BITARTRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, DELAYED RELEASE PELLETS
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-04-30
END MARKETING DATE: 0000-00-00


PROCYSBI HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPROCYSBI from Horizon Pharma Inc.
LABELER NAME: Horizon Pharma Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 25(mg/1)
START MARKETING DATE: 2013-04-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 75987-100_4a275d2d-2b7c-49c8-b1ca-68604b962db2
PRODUCT NDC: 75987-100
APPLICATION NUMBER: NDA203389

Other CYSTEAMINE BITARTRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Horizon Pharma Inc.PROCYSBI
Mylan Pharmaceuticals Inc.Cystagon
Raptor Therapeutics Inc.PROCYSBI